Nanjing Leads Biolabs Joins Hang Seng Composite IndexNanjing Leads Biolabs Co., Ltd. said its shares will be added to the Hang Seng Composite Index effective March 9, 2026, and will also be included in the Stock Connect Southbound Trading Link eligible list
Reuters03-06
Nanjing Leads Biolabs Joins <a href="https://laohu8.com/S/HSNGF">Hang Seng</a> Composite Index Nanjing Leads Biolabs Co., Ltd. said its shares will be added to the <a href="https://laohu8.com/S/HSNGY">Hang Seng</a> Composite Index effective March 9, 2026, and will also be included in the Stock Connect Southbound Trading Link eligible list
Nanjing Leads Biolabs Co., Ltd. (stock code: 9887) said its shares will be added as a constituent of the Hang Seng Composite Index effective March 9, 2026. The company said the inclusion reflects capital market recognition of its performance and value and is expected to broaden its investor base and improve trading liquidity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260306-12044094), on March 06, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments